Neurosense Therapeutics Ltd. ( ($NRSN) ) has shared an announcement. On December 22, 2025, NeuroSense Therapeutics reported that a safety analysis ...

NeuroSense (NRSN) reported completion of the safety analysis from its proof-of-concept Phase 2, randomized, double-blind, placebo-controlled ...

Clinical and Biomarker Outcomes Expected to Be Reported in Q1 2026CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: ...

The state psychiatric facility still doesn’t have an electronic system for tracking medical records. Health officials say they’re reapplying for federal certification anyway.

Investing.com -- Neurosense Therapeutics Ltd (NASDAQ:NRSN) stock rose 5.5% on Monday after the company reported positive safety data for its Alzheimer’s disease treatment candidate.

Background The likelihood of HIV acquisition is increased following forced vaginal sex. This relates in part to ...

Obeng, F. and Ali, M. (2025) The African Child Provides Us with a New Mechanism for “Fall Astride Injury”: A Narrative Review. Open Journal of Urology, 15, 589-604. doi: 10.4236/oju.2025.1512063 .

University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30 ...

The Quantitative Aptitude section of the IBPS RRB PO 2025 Mains Exam is important that helps the candidates to boost the ...

From the rise of agentic AI to the changing face of search, the impact of technology on marketing will be even more pronounced in 2026.

Introduction Armed conflict severely impacts health, with indirect deaths often exceeding direct casualties two to four times ...